Assessment of T-cell reactivity to the SARS-CoV-2 omicron variant by immunized individuals

L De Marco, S D'Orso, M Pirronello… - JAMA network …, 2022 - jamanetwork.com
Importance The emergence of the highly contagious Omicron variant of SARS-CoV-2 and
the findings of a significantly reduced neutralizing potency of sera from individuals with …

Preserved T cell reactivity to the SARS-CoV-2 Omicron variant indicates continued protection in vaccinated individuals

L De Marco, S D'Orso, M Pirronello, A Verdiani… - BioRxiv, 2021 - biorxiv.org
Importance The emergence of the highly contagious Omicron variant of SARS-CoV-2 and
the findings of a significantly reduced neutralizing potency of sera from convalescent or …

T‐cell responses to SARS‐CoV‐2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine

Y Li, X Wang, J Jin, Z Ma, Y Liu… - Journal of medical …, 2022 - Wiley Online Library
The rapidly spreading severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
Omicron variant contains more than 30 mutations that mediate escape from antibody …

[PDF][PDF] T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

V Naranbhai, A Nathan, C Kaseke, C Berrios, A Khatri… - Cell, 2022 - cell.com
Summary The SARS-CoV-2 Omicron variant (B. 1.1. 529) contains mutations that mediate
escape from antibody responses, although the extent to which these substitutions in spike …

Neutralisation sensitivity of the SARS-CoV-2 omicron (B. 1.1. 529) variant: a cross-sectional study

DJ Sheward, C Kim, RA Ehling, A Pankow… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background The SARS-CoV-2 omicron (B. 1.1. 529) variant, which was first
identified in November, 2021, spread rapidly in many countries, with a spike protein highly …

Assessment of antibody and T-cell responses to the SARS-CoV-2 virus and omicron variant in unvaccinated individuals recovered from COVID-19 infection in Wuhan …

L Guo, Q Zhang, C Zhang, T Huang, L Ren… - JAMA Network …, 2022 - jamanetwork.com
The SARS-CoV-2 Omicron variant, which harbored 32 mutations in spike glycoproteins (S),
1 raised concern over the virus escaping from immunity induced by vaccination or natural …

Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients

CH GeurtsvanKessel, D Geers, KS Schmitz… - Science …, 2022 - science.org
The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …

SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants

MA de La Vega, E Polychronopoulou… - Emerging Microbes & …, 2023 - Taylor & Francis
During a pandemic, effective vaccines are typically in short supply, particularly at onset
intervals when the wave is accelerating. We conducted an observational, retrospective …

[PDF][PDF] Limited cross-variant immune response from SARS-CoV-2 Omicron BA. 2 in naïve but not previously infected outpatients

HK Lee, L Knabl, M Walter, PA Furth, L Hennighausen - Iscience, 2022 - cell.com
Omicron is currently the dominant SARS-CoV-2 variant and several sublineages have
emerged. Questions remain about the impact of previous SARS-CoV-2 exposure on cross …

Analysis of previous infection, vaccinations, and anti–SARS-CoV-2 antibody titers and protection against infection with the SARS-CoV-2 Omicron BA. 5 variant

S Yamamoto, T Mizoue, N Ohmagari - JAMA network open, 2023 - jamanetwork.com
The number of patients with COVID-19 has surged during the Omicron pandemic worldwide.
It remains unclear whether and how previous SARS-CoV-2 infection and vaccine-induced …